NorthWest Biotherapeutics Inc (NWBO)

[Umibe5690]

I don't know that they have or have not been achieved. I have admitted that. My explanation in connection with the share price involves the supposition IF. IF the primary and/or secondary endpoints are not met, then, most likely, the market will react negatively because its perception may likely be that the trial failed despite other positive data which will be treated extracurricularly, mostly as an afterthought and as a "spin' defensive argument. I believe, but do not know for sure, that the endpoints may be in jeopardy and that is why PFS blended data has not been addressed and why adjudication is/will be performed.

What I think about milestone survival rates, etc. is irrelevant to the point I am making above. JMHO.